| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849906 | American Heart Journal | 2015 | 11 Pages |
Abstract
Among patients with chronic HFrEF and elevated galectin-3 concentrations, we found no specific benefit from addition or intensification of MRA therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Parul U. MD, Shweta R. MD, Arianna M. BS, Hanna K. MD, MPH, Rory B. MD, Aaron L. MD, Mona PharmD, Hans-Peter MD, James L. MD,